CancerCare Manitoba Research

CancerCare Manitoba Research This page is dedicated to fundamental research in biology and its relation to health, cancer, and related diseases in CancerCare Manitoba.

Scientists study such challenging problems as the molecular origins of cancer, the regulation of gene activity, control of cell movement, inflammation and wound healing, programmed cell death and the biochemical action of cancer chemotherapeutics. Although not a degree-granting institution, the Institute plays a major role in training scientists, whether graduate or postgraduate students, medical

trainees or investigators who come from around the world to work with our staff. Degrees are granted through the faculty of Medicine, Departments of Biochemistry and Medical Genetics, Immunology, Pharmacology, Physiology and Medical Microbiology. Information on training programs can be obtained from our office and the Dean of Graduate Studies.

06/05/2026
Congratulations to Dr. Athanasios Zovoilis and his team, who recently received a Manitoba Solutions Grant through Resear...
06/02/2026

Congratulations to Dr. Athanasios Zovoilis and his team, who recently received a Manitoba Solutions Grant through Research Manitoba.

Their project, AI4Omics-MB, will explore how artificial intelligence can be applied to genetic data from Manitoba patients to improve cancer detection, support more personalized treatment, and enhance clinical decision-making.

By leveraging data from the Manitoba Tumour Bank and PrairieGen, this research is grounded in the needs of Manitoba patients, healthcare providers, and our healthcare system.

The project will also help build local expertise in AI and genomics, strengthen research partnerships, and further position Manitoba as a leader in AI-driven cancer care.

Learn more about the project and its potential impact: https://www.cancercare.mb.ca/About-Us/communications-and-public-affairs/news-archive/AI4Omics-MB-Using-Artificial-Intelligence-to-Advance-Cancer-Care-in-Manitoba

05/26/2026
05/20/2026

We are launching a new program to improve care for people living with Sickle Cell Disease (SCD).

We’re inviting individuals with SCD, as well as parents, guardians, and caregivers, to join small Zoom group discussions and share their lived experience to help shape future care.

Participants will receive an honourarium for their time.

If interested, please fill out the expression of interest form here https://forms.office.com/pages/responsepage.aspx?id=UmsbEbOCP0uzFBsYWEDdKgLiDNNONwRNoMciVvJ7c_FUMFFPMDdUWEowOTgwWDRDMDk1N1lDQzJKUC4u&route=shorturl

05/15/2026

Congratulations to CCMB Hematologist and University of Manitoba Professor Dr. Ryan Zarychanski on being awarded a Tier 1 Canada Research Chair in Clinical Trials.

This prestigious recognition is awarded to researchers who are internationally recognized leaders in their field and conducting groundbreaking research with significant impact.

Dr. Zarychanski’s work focuses on modernizing clinical trials by embedding them directly into patient care to improve outcomes, efficiency, and access for patients.

Address

675 McDermot Avenue
Winnipeg, MB
R3E0V9

Telephone

+12047872234

Website

Alerts

Be the first to know and let us send you an email when CancerCare Manitoba Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CancerCare Manitoba Research:

Shortcuts

Share

Category